Hyams, D., Byun, J., Martin, B., Bailey, C., Stumpf, T. and Petkov, V. 2023. Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s223. DOI:https://doi.org/10.25251/skin.7.supp.223.